Afexa Life Sciences Inc  

(Public, TSE:FXA)   Watch this stock  
Find more results for FXA
- Close
TSE data delayed by 15 mins - Disclaimer
Currency in
Range     -
52 week 0.35 - 0.95
Open     -
Vol. 0.00
Mkt cap     -
P/E     -
Div/yield     -
EPS -0.05
Shares     -
Beta     -
Inst. own     -

Key stats and ratios

Q3 (Sep '11) 2011
Net profit margin -1.05% -2.07%
Operating margin 1.60% -2.95%
EBITD margin - -1.37%
Return on average assets -1.68% -2.05%
Return on average equity -2.76% -3.21%
Employees 107 -
CDP Score - -


9604, 20th Avenue
+1-780-4320022 (Phone)
+1-780-4327772 (Fax)

Website links


Afexa Life Sciences Inc. (Afexa) is a life sciences and technology company. The Company is engaged primarily in the research, development and commercialization of natural medicines for health maintenance and disease prevention. It has developed and commercialized a technology, known as ChemBioPrint, which it used to discover and two-dimensionally standardize natural health products. Its product includes COLD-FX, COLD-FX Extra, IMMUNITY-FX, REMEMBER-FX, MEMORY-FX and CELL-FX. Its COLD-FX is designed to aid in the prevention and relief of colds and flu by strengthening the immune system. IMMUNITY-FX is consisted of a special formulation to help the immune system fight germs and pathogens that are foreign to the body. Its REMEMBER-FX product is sold in Canada to help restore mental alertness or wakefulness when experiencing fatigue or drowsiness. CELL-FX is a natural health product designed to help relieve symptoms of bone and joint pain and to help in the formation of connective tissue.